Citadel Advisors »

Mink Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Mink Therapeutics (INKT) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Mink Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mink Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mink Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $45k 42k 1.07
2023-06-30 $107k 51k 2.10

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Mink Therapeutics

Vanguard Group
Longbow Finance SA
Captrust Financial Advisors
HighTower Advisors
Citadel Advisors
Oracle Investment Management
Bank of America Corporation
Goldman Sachs Group
Jane Street
Wells Fargo & Company
Virtu Financial
UBS Group
Artal Group
Covestor
Royal Bank of Canada

View all funds holding Mink Therapeutics